A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. (Q39901967)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mark G Kris

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mario E Lacouture

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Dennis West

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Michael L Maitland

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Siegfried Segaert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ann Setser

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Robert Baran

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Lindy P Fox

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Joel B Epstein

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Andrei Barasch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Lawrence Einhorn

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Lynne Wagner

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Beth Eaby

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sandra Kurtin

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Elise A Olsen

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Alice Chen

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Janet E Dancey

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Andy Trotti

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ethan Basch

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

10 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

Supportive Care in Cancer

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

509-522

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20145956%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00520-009-0744-x

18 January 2020

exact match

0 references

cites work

Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225

1 reference

12 December 2020

Completeness in the reporting of dermatologic adverse drug reactions associated with monoclonal antibody epidermal growth factor receptor inhibitors in phase II and III colorectal cancer clinical trials

1 reference

12 December 2020

Evaluation of early and late toxicities in chemoradiation trials.

1 reference

12 December 2020

Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients

1 reference

12 December 2020

Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks

1 reference

12 December 2020

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks

1 reference

12 December 2020

Is there room for improvement in adverse event reporting in the era of targeted therapies?

1 reference

12 December 2020

Mechanisms of cutaneous toxicities to EGFR inhibitors.

1 reference

12 December 2020

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors

1 reference

12 December 2020

ERBB receptors and cancer: the complexity of targeted inhibitors

1 reference

12 December 2020

A nail psoriasis severity index

1 reference

12 December 2020

Nail toxicity associated with epidermal growth factor receptor inhibitor therapy

1 reference

12 December 2020

Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation

1 reference

12 December 2020

Patient-reported outcomes and the evolution of adverse event reporting in oncology

1 reference

12 December 2020

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

12 December 2020

Dermatologic toxicities associated with EGFR inhibitors: the clinical psychologist's perspective. Impact on health-related quality of life and implications for clinical management of psychological sequelae.

1 reference

12 December 2020

Erlotinib in previously treated non-small-cell lung cancer

1 reference

12 December 2020

Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?

1 reference

12 December 2020

Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results

1 reference

12 December 2020

Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy.

1 reference

12 December 2020

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

1 reference

12 December 2020

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

1 reference

12 December 2020

Issues and progress with protein kinase inhibitors for cancer treatment

1 reference

12 December 2020

Ocular toxicities of epidermal growth factor receptor inhibitors and their management

1 reference

12 December 2020